The national campaign encourages communities
to participate via social media and gives access to education
resources and proper disposal methods
ALEXANDRIA, Va., Aug. 1, 2024
/PRNewswire/ -- CADCA, in partnership with the Deterra® Drug
Deactivation and Disposal System, announced today the launch of the
'Over the Dose Challenge,' a nationwide campaign running
August 1, 2024 – October 31, 2024 dedicated to educating
communities about the dangers of keeping unused prescription drugs
at home and promoting safe, effective disposal methods.
Through this inaugural campaign, CADCA encourages communities to
participate by disposing of unused and expired prescription
medications and sharing their stories on social media with the
hashtag #OverTheDose. The campaign also includes resources on
CADCA's website about the dangers of unused or expired prescription
medications, proper disposal methods, and success stories.
"Prescription medication misuse is a serious issue impacting
families and communities nationwide," said General Barrye L. Price, Ph.D., President and Chief
Executive Officer of CADCA. "With this campaign we want to make an
impact on affected communities by providing resources and tools for
individuals to safely dispose of unused prescription medications,
thereby reducing the risk of drugs falling into the wrong
hands."
A recent JAMA study shows that the odds of opioid-related
overdose increases by 60% when another household member had an
opioid prescription filled in the past 6 months. The results
suggest that household prescription availability is associated with
increased odds of opioid overdose for others in the household, even
if they do not have their own opioid prescription. In addition to
drug misuse, other risks of not disposing of unused prescriptions
include accidental ingestion and environmental harm. This can be
counteracted by proper education and tools, such as access to Verde
Environmental Technologies, Inc.'s Deterra Drug Deactivation and
Disposal Pouches.
Deterra Pouches uses organic activated carbon and tap water to
render drugs inert, making them unretrievable for misuse and safe
to throw away in the household trash without contaminating
landfills or waterways. It is the only product available that is
scientifically proven to destroy prescription and over-the-counter
medicine, right at home.
"Proper disposal of prescription drugs is a simple yet effective
way to make our communities safer," said Jason Sundby,
President of Verde Environmental Technologies, Inc. 'The Over the
Dose Challenge' is an important program to educate and empower
individuals to take action and protect their loved ones and
environment."
For more information about the campaign, visit
cadca.org/over-the-dose and follow us on social @CADCA and
@DeterraSystem. Tag the campaign using the hashtag
#OverTheDose.
About CADCA
CADCA is the premier prevention association, representing over
7,000 community-based coalitions across the United States and territories and more
than 30 countries around the world who work to create safer,
healthier, and stronger communities. CADCA provides resources,
customized training, and signature events designed to help our
coalitions be effective and sustainable. The CADCA model emphasizes
the power of community coalitions to prevent substance misuse
through collaborative efforts.
About Verde Environmental Technologies, Inc.
Minneapolis-based Verde
Environmental Technologies, Inc., is a privately owned company
committed to developing research-based scientifically proven
solutions to reduce drug, misuse and negative environmental impact.
The patented Deterra® Drug Deactivation and Disposal System is
powered by proprietary activated carbon, which deactivates drugs.
Deterra is highly effective in adsorbing and firmly binding drugs,
rendering them inert, unavailable for misuse and safe for the
environment. Visit DeterraSystem.com to learn more.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cadca-and-the-deterra-drug-deactivation-and-disposal-system-launch-new-over-the-dose-challenge-to-combat-prescription-drug-misuse-302212501.html
SOURCE CADCA